Recent post hoc analysis of data from a phase II study demonstrated that a significant treatment efficacy of GLP-1 RAs was observed in patients with NASH in terms of steatosis, necroinflammation, and fibrosis in continuous scores.100. This evidence concerns the gene GLP1R and steatosis.